Dr. Melissa Maria Pham, MD

Dr. Pham practices at UC Davis Medical Center in Sacramento, California, part of University of California Health.

Dr. Pham's NPI, 1275982852, was assigned on June 6, 2016. Dr. Pham graduated from Geisinger Commonwealth School of Medicine in 2016. Dr. Pham holds California license 198630.

Dr. Pham's primary practice is UC Davis Medical Center, at 2315 Stockton Boulevard, Sacramento, CA 95817 in Sacramento County. The practice phone is (916) 734-2011.

Dr. Pham's primary practice is UC Davis Medical Center in Sacramento, California, part of University of California Health. Dr. Pham is also affiliated with Enloe Health. The medical group on file is UC Davis Medical Group. Dmand AI also links Dr. Pham to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pham practices, 3 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Pham's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dmand AI has Dr. Pham's licenses on file in 4 states: California, Texas, Vermont and Pennsylvania.

CMS data shows 64 Medicare services from Dr. Pham across 3 procedure codes in 2024, for 51 Medicare patients. Medicare paid $3,228 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 51 Medicare patients who saw Dr. Pham in 2024. The largest group is 65 to 74, with 24 patients. 73% of them have high blood pressure, and 65% have high cholesterol. 35% are also on Medicaid. Their average risk score is 2.12, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Pham's median patient age at 62, with 99% women.

In 2024, Dr. Pham wrote 64 Medicare Part D claims for 20 patients. 97% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $38 in total drug cost. In 2023, CMS named 52 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Pham for performance year 2024, reported as part of a group. Dr. Pham accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Pham as offering telehealth. CMS counts 24 procedures of removal of the uterus by Dr. Pham, more than 95% of the clinicians it reports for that procedure.

Dmand AI links 7 papers to Dr. Pham, published from 2021 to 2025. 2021 was the busiest year, with 2. The most frequent topics are Poly(ADP-ribose) Polymerase Inhibitors, Antineoplastic Agents and Endometrial Neoplasms. Dr. Pham has published most often in Int J Gynecol Cancer. Dr. Pham's most frequent co-authors are Shannon Neville Westin, MD, Monica Avila, MD and Emily Moss Hinchcliff, MD.

CMS Open Payments shows 10 general payments to Dr. Pham from 9 drug and device companies from 2021 to 2025. Grants make up the largest share, 99% of the total. AstraZeneca Pharmaceuticals LP paid the most, $50,000.

Dr. Pham graduated from Geisinger Commonwealth School of Medicine in 2016. Dr. Pham is a member of ACOG.

Dr. Pham is in network with 5 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Regence Health Plans. Medicare plans come from the most carriers, 4. Check the plan with the practice before a visit.